Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Cannamerica Brands Corp CNNXF

Healthcare Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Cannabis
CannAmerica Brands Corp is involved in the Medical and Recreational Cannabis in the United States. The company's principal business is to build on and maximize the value of its brands by promoting, marketing, and licensing these brands through various distribution channels, including dispensaries, wholesalers, and distributors in the United States.


GREY:CNNXF - Post by User

Cannamerica Brands Corp > Huh
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(1)
•••
Comment by nomoneyon Feb 15, 2019 7:24pm
39 Views
Post# 29373802

RE:Huh

RE:HuhThere were two cash trades that went through at .37 for 5000 shares each.  So you weren’t seeing thing!
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities